Inference of dynamic biological networks based on responses to drug perturbations
Noah Berlow1, Lara Davis2, Charles Keller2
1Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, 79409 TX USA.
Abstract:
Drugs that target specific proteins are a major paradigm in cancer research. In this article, we extend a modeling framework for drug sensitivity prediction and combination therapy design based on drug perturbation experiments. The recently proposed target inhibition map approach can infer stationary pathway models from drug perturbation experiments, but the method is limited to a steady-state snapshot of the underlying dynamical model. We consider the inverse problem of possible dynamic models that can generate the static target inhibition map model. From a deterministic viewpoint, we analyze the inference of Boolean networks that can generate the observed binarized sensitivities under different target inhibition scenarios. From a stochastic perspective, we investigate the generation of Markov chain models that satisfy the observed target inhibition sensitivities.
Insights
This study develops dynamic models for cancer drug sensitivity prediction. It extends existing methods to infer potential biological pathway dynamics from static drug perturbation data, improving combination therapy design.
Area of Science:
- Computational biology
- Systems biology
- Cancer research
Background:
- Targeted protein inhibitors are crucial in cancer research.
- Current models infer static pathway behavior from drug perturbation data.
- Existing methods capture only a steady-state snapshot, limiting dynamic insights.
Purpose of the Study:
- To extend modeling frameworks for drug sensitivity prediction and combination therapy design.
- To infer dynamic models that can generate observed static target inhibition maps.
- To explore deterministic and stochastic approaches for modeling biological system dynamics.
Main Methods:
- Inferred Boolean networks from binarized drug sensitivities under target inhibition.
- Investigated Markov chain models from stochastic perspectives.
- Analyzed the inverse problem of dynamic models generating static target inhibition maps.
Main Results:
- Identified deterministic Boolean networks capable of producing observed drug sensitivities.
- Developed stochastic Markov chain models consistent with target inhibition data.
- Extended static target inhibition maps to dynamic pathway models.
Conclusions:
- Dynamic modeling offers deeper insights into drug responses than static models.
- This framework enhances prediction of drug sensitivity and combination therapy efficacy.
- The approach provides a more comprehensive understanding of cancer signaling pathways.
More Related Videos
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Responses: Different Types
Pharmacokinetic–Pharmacodynamic Relationship: Problems


